Laurus Labs Limited has informed the Exchange regarding a press release dated May 31, 2023, titled "Laurus Labs further invests in Cell and Gene therapy company ImmunoACT; to hold 33.86% stake post- completion of the transaction".
Press Release May 31 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Laurus Labs
- Press Release May 02 2023
- Press Release Apr 27 2023
- Press Release Jan 30 2023
- Press Release Oct 21 2022
- Press Release Jul 27 2022
Later from Laurus Labs
- Press Release Jun 19 2023
- Press Release Jul 27 2023
- Press Release Oct 20 2023
- Press Release Jan 24 2024
- Press Release Jan 25 2024
Follow Laurus Labs into a list and get an email when it puts out news.
Follow Laurus Labs